Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinibAilin Guo(University of Exeter), Y. Lynn Wang(Southwest Medical University)OncotargetDecember 22, 201510.18632/oncotarget.6727Cited by 55SaveCiteExport RISWatch citationsRelated PapersDual SYK/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: Cerdulatinib, but not ibrutinib, induces apoptosis of tumor cells protected by the microenvironment|Oncotarget|2017|51